The latest scientific, medical and assistance advances in Pathological Anatomy in Mastology, compiled in a complete high-performance Postgraduate certificate"

The aspect referring to surgical, chemotherapy, radiotherapy and oncogenetic treatment during specialized medical training is relatively short and insufficient due to the lack of the necessary curricular time to go into it in depth. Because of this, many medical professionals in formation and specialists are demanding more training in this area. This is in addition to the evolution experienced in this field in recent years, both in the diagnostic space and, above all, in the management of patients; in this respect, the so-called precision oncology, with criteria of multimodality, individuality and patient-centeredness, would be a paradigm. Circumstances that make the constant renewal of knowledge essential, since the current evolution is one of exponential growth to which it is difficult to adapt without the appropriate continuous training.

The growing complexity of new treatments and decision making, as well as the introduction of neoadjuvant chemotherapy in the treatment of malignant pathology, means that the physician responsible for the treatment of these patients must be familiar with all the new aspects in order to manage resources more efficiently and obtain the best results.  

This Postgraduate certificate has been developed to provide an effective and quality response to the needs of intensive and compatible preparation, that professionals in this area are requiring. A tour of the highest quality, from the hand of the best professionals in the sector.

A unique Postgraduate certificate that perfectly combines preparatory intensity with the most innovative knowledge and techniques in the sector, with the flexibility that the working professional needs”

This Postgraduate certificate in Pathological Anatomy in Mastology contains the most complete and up-to-date scientific program on the market. The most important features include:

• Development of a large number of practical cases, presented by experts
• Graphic, schematic, and highly practical contents
• The latest developments and cutting-edge advances in this field
• Practical Exercises where the Self-assessment Process can be Carried Out in Order to Improve Learning
• Innovative and highly efficient methodologies
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

The latest advances in the area of Pathological Anatomy in Mastology compiled in a Postgraduate certificate of high preparatory efficiency, which will optimize your effort with the best results”

The development of this Postgraduate certificate is focused on the practice of the proposed theoretical learning. Through the most effective teaching systems, proven methods imported from the most prestigious universities in the world, you will be able to acquire new knowledge in a practical way. In this way, we strive to convert your efforts into real and immediate skills.

Our online system is another of the strengths of our training course. With an interactive platform, which has the advantages of the latest technological developments, we put at your service the most participatory digital tools. In this way, we can offer you a way of learning that is totally adaptable to your needs, so that you can perfectly balance this program with your personal or professional life.

Improve the quality of care for your patients with this scientifically rigorous Postgraduate certificate"

An educational program created to allow you to implement your acquired knowledge into your daily practice in an almost immediate way"

The structure of the contents has been designed by a team of professionals, aware of the relevance of specialization in order to advance in the labor market with security and competitiveness, and to provide professional practice with the excellence that only the best training allows.

This innovative Postgraduate certificate in Pathological Anatomy in Mastology contains the most complete and up-to-date scientific program on the market”

Module 1. Pathologic Anatomy

1.1. Introduction to Breast Pathological Anatomy

1.1.1. Concepts. Anatomopathological Language
1.1.2. Methods for Studying Pathological Anatomy
1.1.3. Types of Samples
1.1.4. Clinical and Radiological Correlation

1.1.4.1. Surgical Specimen Orientation

1.1.5. Diagnosis: The Anatomopathological Report
1.1.6. Normal Breast

1.2. Benign Epithelial Tumors Papillary Neoplasms Premalignant Lesions

1.2.1. Benign Epithelial Proliferations and Precursors

1.2.1.1. Usual Ductal Hyperplasia
1.2.1.2. Columnar Cell Lesions, Including Flat Epithelial Atypia
1.2.1.3. Atypical Ductal Hyperplasia

1.2.2. Adenosis and Benign Sclerosing Lesions 

1.2.2.1. Sclerosing Adenosis
1.2.2.2. Adenosis and Apocrine Adenoma
1.2.2.3. Adenosis Microglandular
1.2.2.4. Radial Scar and Complex Sclerosing Lesion

1.2.3. Adenomas

1.2.3.1. Tubular Adenoma
1.2.3.2. Lactational Adenoma
1.2.3.3. Ductal Adenoma

1.2.4. Epithelial-Myoepithelial Tumors 

1.2.4.1. Pleomorphic Adenoma
1.2.4.2. Adenomyoepithelioma

1.2.5. Papillary Neoplasms

1.2.5.1. Intraductal Papilloma
1.2.5.2. Papillary Ductal Carcinoma in situ
1.2.5.3. Encapsulated Papillary Carcinoma
1.2.5.4. Solid Papillary Carcinoma in situ

1.2.6. Non-Invasive Lobular Neoplasia

1.2.6.1. Atypical Lobular Hyperplasia
1.2.6.2. Lobular Carcinoma in situ

1.2.7. Ductal Carcinoma in situ

1.3. Malignant Epithelial Tumors

1.3.1. Infiltrating Carcinoma and Subtypes

1.3.1.1. Infiltrating Carcinoma Without a Special Subtype
1.3.1.2. Microinfiltrating Carcinoma
1.3.1.3. Infiltrating Lobular Carcinoma
1.3.1.4. Tubular Carcinoma
1.3.1.5. Cribriform Carcinoma
1.3.1.6. Mucinous Carcinoma
1.3.1.7. Mucinous Cystadenocarcinoma
1.3.1.8. Infiltrating Micropapillary Carcinoma
1.3.1.9. Infiltrating Solid Papillary Carcinoma
1.3.1.10. Infiltrating Papillary Carcinoma
1.3.1.11. Carcinoma with Apocrine Differentiation
1.3.1.12. Metaplastic Carcinoma

1.3.2. Saliva Gland Type Carcinomas

1.3.2.1. Acinar Cell Carcinoma
1.3.2.2. Adenoid Cystic Carcinoma 
1.3.2.3. Secretor Carcinoma
1.3.2.4. Mucoepidermoid Carcinoma
1.3.2.5. Polymorphous Adenocarcinoma
1.2.2.6. Tall Cell Carcinoma with Reverse Polarization

1.3.3. Neuroendocrine Neoplasms

1.3.3.1. Neuroendocrine Tumor
1.3.3.2. Neuroendocrine Carcinoma

1.4. Fibroepithelial Tumors Nipple-areola complex Tumors Hematolymphoid Tumors

1.4.1. Fibroepithelial Tumors

1.4.1.1. Hamartoma
1.4.1.2. Fibroadenoma
1.4.1.3. Tumor Phyllodes

1.4.2. Nipple-areola Complex Tumors

1.4.2.1. Syringomatous Tumor
1.4.2.2. Nipple Adenoma
1.4.2.3. Paget’s Disease of the Breast

1.4.3. Hematolymphoid Tumors

1.4.3.1. MALT Lymphoma
1.4.3.2. Follicular Lymphoma
1.4.3.3. Diffuse Large B-cell Lymphoma
1.4.3.4. Burkitt Lymphoma
1.4.3.5. Anaplastic Large Cell Lymphoma Associated with Breast Implantation

1.5. Mesenchymal Tumors

1.5.1. Vascular Tumours.

1.5.1.1. Hemangioma
1.5.1.2. Angiomatosis
1.5.1.3. Atypical Vascular Lesions
1.5.1.4. Primary Angiosarcoma
1.5.1.5. Post-Radiation Angiosarcoma

1.5.2. Fibroblastic and Myofibroblastic Tumors

1.5.2.1. Nodular Fascitis
1.5.2.2. Myofibroblastoma
1.5.2.3. Desmoid Fibromatosis
1.5.2.4. Inflammatory Myofibroblastic Tumor

1.5.3. Peripheral Nerve Sheath Tumors

1.5.3.1. Schwannoma
1.5.3.2. Neurofibroma
1.5.3.3. Granular Cells Tumor

1.5.4. Smooth Muscle Tumors

1.5.4.1. Leiomyoma
1.5.4.2. Leiomyosarcoma

1.5.5. Adipocytic Tumors

1.5.5.1. Lipoma
1.5.5.2. Angiolipoma
1.5.5.3. Liposarcomas

1.6. Clinical Pathological Special Situations Genetic Tumor Syndromes

1.6.1. Clinical Pathological Special Situations

1.6.1.1. Young Woman
1.6.1.2. Pregnancy and Lactation
1.6.1.3. Elderly Woman
1.6.1.4. Men
1.6.1.5. Hidden
1.6.1.6. Inflammatory Carcinoma

1.6.2. Genetic Tumor Syndromes

1.6.2.1. BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome
1.6.2.2. Cowden Syndrome
1.6.2.3. Ataxia-Telangiectasia
1.6.2.4. CHEK2-Associated Li-Fraumeni Syndrome
1.6.2.5. CHEK2-Associated Li-Fraumeni Syndrome
1.6.2.6. CDH1-Associated Breast Cancer
1.6.2.7. Cancer Associated with PALB2
1.6.2.8. Peutz-Jeghers Syndrome
1.6.2.9. Neurofibromatosis Type I

1.7. Non-Tumorous Pathology

1.7.1. Pseudoangiomatous Stromal Hyperplasia
1.7.2. Diabetic Mastopathy
1.7.3. Fibrosis
1.7.4. Mondor Disease
1.7.5. Changes Due to Breastfeeding
1.7.6.  Mastitis

1.7.6.1. Mastitis Granulomatosa
1.7.6.2. Mastitis Non-Granulomatosa

1.8. Prognosis

1.8.1. Tumor Grade
1.8.2. Pathological Staging
1.8.3. Surgical Border
1.8.4. Sentinel Lymph Node  

1.8.4.1. OSNA 

1.8.5. Treatment-Oriented Immunohistochemistry Classes
1.8.6. Nomograms

1.8.6.1. Cases

1.9. Prediction 

1.9.1. Evaluation of Response to Neoadjuvant Treatment
1.9.2. Prediction of the Response to Chemotherapy Treatment

1.9.2.1. Genetic Platforms Oncotye DX, Mamaprint, PAM50

1.9.3. Therapeutic Targets
1.9.4. NGS 
1.9.5. Digital and Computational Pathology 

1.9.5.1. Cases

1.10.  Multimodality 

1.10.1. Positive, Negative or Uncertain  
1.10.2. Interpretation of Data in the Clinical Context  

1.10.2.1. Statistics and Probability  

1.10.3. Quality Control  

1.10.3.1. Protocols 

1.10.4. Pathologists in the Breast Unit 

1.10.4.1. Difficult Cases: are tumors, occult primary, non-breast OSNA, very long monitoring processes

1.10.5. Conclusions

A unique, key, and decisive training experience , to boost your professional development”